Back to top
more

Primecap Odyssey Growth Fund: (MF: POGRX)

(NASDAQ Mutual Funds) As of Jun 21, 2018 08:15 PM ET

 Add to portfolio

$42.28 USD

+0.23 (0.55%)

Zacks MF Rank 3-Hold     3    

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of May 31, 2018

Total Return %* Percentile Rank Objective
YTD 10.55 7
3 months 2.64 25
6 months 11.01 7
1 Year 28.13 2
3 Year 17.04 1
5 Year 16.96 2
10 Year 12.69 1

* Annual for three years and beyond.

Zacks Premium Research for POGRX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Hold 3
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 45.74
% Yield 0.25
% SEC Yield
Net Assets (Mil $) 5/31/2018 13,110.98
%Turnover 5/31/2018 5.00

Risk

3 Year 5 Year 10 Year
Beta 1.15 1.05 1.05
Alpha 4.39 3.19 3.14
R Squared 0.72 0.69 0.85
Std. Dev. 13.89 12.56 17.10
Sharpe 1.25 1.38 1.00

Sector / Country Weightings

As of 5/31/2018 % of Portfolio
Technology 29.24
Health 24.59
Industrial Cyclical 13.47
Other 8.38
Finance 8.00
Retail Trade 6.26
Non-Durable 4.60
Services 4.51
Consumer Durables 0.35
Utilities 0.35
Energy 0.25

Portfolio Holdings

Top Equity Holdings
(As of 1/31/2018)
% of Portfolio Value (Mil$)
NEKTAR THERAPEUTICS 5.14 607.79
ABIOMED INC 3.63 430.00
ALKERMES PLC 3.36 397.92
ALIBABA GROUP HOLDING LTD 2.64 312.16
AMERICAN AIRLINES GROUP I 2.57 303.50
SEATTLE GENETICS INC 2.44 289.10
MICRON TECHNOLOGY INC 2.33 276.09
ELI LILLY & CO 2.31 272.78
ETRADE FINANCIAL CORP 2.23 264.03

Stock Holding % of Net Assets

As Of 1/31/2018
Total Issues 136
Avg. P/E 31.46
Avg. P/Book 4.89
Avg. EPS Growth 12.37
Avg. Market Value (Mil $) 86,931

Allocation

% of Portfolio
Large Growth 37.53
Large Value 18.28
Small Growth 22.97
Small Value 0.00
Foreign Stock 10.06
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00